Publications by authors named "Peiyi Xie"

The literature suggests that hepatocellular Yes-associated protein 1 (YAP1) signaling is activated following hepatectomy and that such activation can suppress the growth of metastatic liver tumors. The prognosis of a real-world cohort of 240 patients with colorectal cancer liver metastasis (CRLM) undergoing major and minor hepatectomy was compared after adjusting for confounding factors. To model CRLM, we induced liver metastasis in mice by transsplenically injecting MC38 cells.

View Article and Find Full Text PDF

Objective: This study aimed to investigate the relationship between the triglyceride-glucose (TyG) index and the presence of severe left main and/or three-vessel disease (LM/3VD) evaluated by SYNTAX score.

Design: Cross-sectional study.

Setting: Shenzhen Nanshan People's Hospital and The First Affiliated Hospital of Jinan University.

View Article and Find Full Text PDF

Tumor-infiltrating myeloid cells (TIMs) are pivotal cell populations involved in the immunosuppressive tumor immune microenvironment (TIME). However, there has been little success in large-scale clinical trials of myeloid cell modulators. We aim to investigate potential molecular targets for TIMs and disclose the underlying mechanism.

View Article and Find Full Text PDF

Background: Systematic MRI findings of solitary rectal ulcer syndrome (SRUS) are lacking. We aimed to evaluate the MRI findings of SRUS and to identify the MRI features that differentiate SRUS from rectal cancer.

Methods: This retrospective study consecutively included 30 patients diagnosed with SRUS from January 2015 to December 2021.

View Article and Find Full Text PDF

Background: The efficacy of immune checkpoint inhibitors (ICIs) for hepatocellular carcinoma (HCC) is limited by heterogeneity in individual responses to therapy. The heterogeneous phenotypes and crucial roles of cancer-associated fibroblasts (CAFs) in immunotherapy resistance remain largely unclear.

Methods: A specific CAF subset was identified by integrating comprehensive single-cell RNA sequencing, spatial transcriptomics and transcriptome profiling of patients with HCC with different responses to antiprogrammed cell death protein 1 (anti-PD-1) therapy.

View Article and Find Full Text PDF

Excessive inorganic ions in water sources can accumulate abnormally or be deficient in the human body, leading to serious health risks, such as liver and kidney damage or even cancer. Therefore, efficient and accurate detection of excessive inorganic ions in water is urgently needed. Using an in situ encapsulation method under solvothermal conditions, we develop a series of triple-emission fluorescent sensors, C6&RhB@UiO-66-Ph (C&R@U), by encapsulating green-emitting Coumarin 6 (C6) and red-emitting Rhodamine B (RhB) into a blue-emitting UiO-66-Ph MOF with 1,4-HNDC as the ligand.

View Article and Find Full Text PDF

Objectives: To analyze the CT imaging features of extranodal natural killer/T (NK/T)-cell lymphoma, nasal type (ENKTCL-NT) involving the gastrointestinal tract (GI), and to compare them with those of Crohn's disease (CD) and diffuse large B-cell lymphoma (DLBCL).

Materials And Methods: Data were retrospectively collected from 17 patients diagnosed with GI ENKTCL-NT, 68 patients with CD, and 47 patients with DLBCL. The CT findings of ENKTCL-NT were analyzed and compared with those of CD and DLBCL.

View Article and Find Full Text PDF

Lecithin cholesterol acyltransferase (LCAT), a crucial enzyme in lipid metabolism, plays important yet poorly understood roles in tumours, especially in hepatocellular carcinoma (HCC). In this study, our investigation revealed that LCAT is a key downregulated metabolic gene and an independent risk factor for poor prognosis in patients with HCC. Functional experiments showed that LCAT inhibited HCC cell proliferation, migration and invasion.

View Article and Find Full Text PDF

The synthesis of multi-wavelength emission fluorescent metal-organic framework sensors has received widespread attention in recent years. Under solvothermal conditions, a series of triple-emission fluorescent sensors were fabricated by in situ encapsulation of red emitting Eosin Y and green emitting 9,10-bis(phenylethynyl)anthracene (BPEA) into a blue emitting naphthalene-based Zr-MOF. By combining the dye quantity regulation and the resonance energy transfer between MOFs and dyes, the single-phase EY&BPEA@Zr-MOFs exhibited tunable triple-emission fluorescence.

View Article and Find Full Text PDF

Objectives: Surveillance of rectal cancer recurrence in patients with negative pretreatment carcinoembryonic antigen (CEA) is challenging. This study aimed to develop the magnetic resonance imaging (MRI)-based radiomics models to predict rectal cancer recurrence in CEA-negative patients.

Materials And Methods: This retrospective multicenter study consecutively enrolled rectal cancer patients with negative pretreatment CEA diagnosed between November 2012 and November 2018 from three medical centers.

View Article and Find Full Text PDF

Objective: To explore the sub-regional histogram features of amide proton transfer-weighted (APTw) MRI, compared with those of diffusion-weighted imaging (DWI), in predicting the tumor budding (TB) grade of rectal cancer (RC).

Materials And Methods: This study prospectively enrolled 74 patients with pathologically confirmed RC, who underwent APTw MRI before surgery from July 2022 to March 2023. Hematoxylin-eosin staining was used for TB scoring.

View Article and Find Full Text PDF
Article Synopsis
  • Anti-PD-L1 combination immunotherapy is the first-line treatment for unresectable hepatocellular carcinoma (HCC), but its effectiveness is limited, with less than 40% of patients responding.
  • Research found that nonresponders had higher activation of the renin-angiotensin system and lower ACE2 expression, which is linked to HCC progression and resistance to treatment.
  • Targeting the ACE2 axis may improve responses to anti-PD-L1 therapy by reducing immunosuppressive factors in the tumor environment, positioning it as both a potential therapeutic target and a biomarker for predicting treatment success.
View Article and Find Full Text PDF
Article Synopsis
  • Lenvatinib is a TKI approved for treating hepatocellular carcinoma (HCC), but resistance to it is frequent, prompting research into resistance mechanisms.
  • The study identified GOLM1, a protein associated with the Golgi apparatus, as a key factor in Lenvatinib resistance, found to be overexpressed in resistant HCC cell lines and clinical samples.
  • Targeting GOLM1 may enhance treatment effectiveness by working alongside Lenvatinib, with evidence showing its role in regulating resistance through the EGFR-STAT3-CSN5 signaling pathway.
View Article and Find Full Text PDF
Article Synopsis
  • This study explores how radiogenomic analysis can identify imaging biomarkers linked to DNA methylation in gliomas to improve molecular diagnosis and treatment.* -
  • Machine learning techniques were applied to analyze MRI features from 146 glioma patients, resulting in models (MoRad) that accurately profile various molecular features, particularly global DNA methylation.* -
  • Findings show that global DNA methylation correlates with certain MRI features, histological grades, and various molecular and immunological factors, indicating its potential as a quantitative imaging biomarker.*
View Article and Find Full Text PDF
Article Synopsis
  • Early detection of severe left main or three-vessel disease (LM/3VD) in NSTEMI patients is important for effective treatment choices and risk assessment, but predictors for high SYNTAX scores (SS) in this context were previously under-explored.* -
  • A study of 481 NSTEMI patients revealed that older age and the degree of ST-segment elevation in lead aVR are key independent predictors of severe LM/3VD, with significant statistical findings supporting these factors.* -
  • The findings emphasize the relevance of age and ST-segment changes in electrocardiograms for predicting serious coronary artery issues in NSTEMI patients, which could enhance personalized treatment strategies.*
View Article and Find Full Text PDF

Background: Ischemia with non-obstructive coronary artery disease is a prevalent form of ischemic heart disease. The majority of ischemia with non-obstructive coronary artery disease cases are attributed to underlying factors such as coronary microvascular dysfunction (CMD) and/or coronary artery spasm. Ischemia with non-obstructive coronary artery disease can present with various clinical manifestations.

View Article and Find Full Text PDF

Background & Aims: The effectiveness of immune checkpoint inhibitor (ICI) therapy for hepatocellular carcinoma (HCC) is limited by treatment resistance. However, the mechanisms underlying immunotherapy resistance remain elusive. We aimed to identify the role of CT10 regulator of kinase-like (CRKL) in resistance to anti-PD-1 therapy in HCC.

View Article and Find Full Text PDF

Objectives: To investigate the clinical value of a novel deep-learning based CT reconstruction algorithm, artificial intelligence iterative reconstruction (AIIR), in diagnostic imaging of colorectal cancer (CRC).

Methods: This study retrospectively enrolled 217 patients with pathologically confirmed CRC. CT images were reconstructed with the AIIR algorithm and compared with those originally obtained with hybrid iterative reconstruction (HIR).

View Article and Find Full Text PDF

Background: Liver metastasis (LM) accounts for most colorectal cancer (CRC)-related deaths. However, how metastatic CRC cells gain the ability to survive and grow in liver remains largely unknown.

Methods: First, we screened differentially expressed genes (DEGs) between LM and paired primary tumors (PTs) in Gene Expression Omnibus (GEO) database, and identified cytochrome P450 1B1 ( as the only common differential gene.

View Article and Find Full Text PDF

Background: As a commonly used biomarker in rectal cancer (RC), the prognostic value of carcinoembryonic antigen (CEA) remains underexplored. This study aims to evaluate the prognostic value of pretreatment CEA/tumor volume in RC.

Methods: This retrospective study included patients who underwent pretreatment magnetic resonance imaging (MRI) with histologically confirmed primary rectal adenocarcinoma from November 2012 to April 2018.

View Article and Find Full Text PDF

Hepatocellular carcinoma (HCC) is one of the deadliest malignancies in the world. Research into the key genes that maintain the malignant behavior of cancer cells is crucial for the treatment of HCC. Here, we identified ubiquitin-specific peptidase 44 (USP44), a member of the deubiquitinase family, as a novel regulator of HCC progression.

View Article and Find Full Text PDF

Exosomes (EXOs) are considered natural nanoparticles which have been widely used as carriers for the treatment and diagnosis of various diseases. However, due to the non-specific uptake, the unmodified EXOs cannot effectively deliver the vector to the target site. In this study, we used pDisplay vector to engineer Glypican-3 (GPC3) single-chain scFv antibody to the exosome surface, and the effect of engineered exosomes on the proliferation and migration of hepatocellular carcinoma (HCC) cells was determined by a series of in vitro experiments as well as in vivo mouse xenograft model and PDX model.

View Article and Find Full Text PDF

Background: Residual abnormalities on computed tomography enterography (CTE) in Crohn's disease (CD) with endoscopic healing (EH) may have prognostic implications and affect therapeutic strategy.

Methods: CD patients with EH who underwent CTE between March 2015 and June 2022 were enrolled. CTE findings of the terminal ileum and the most severe segment of colon at the time of EH were assessed respectively for each patient.

View Article and Find Full Text PDF

Purpose: Adjuvant therapy is recommended to minimize the risk of distant metastasis (DM) and local recurrence (LR) in patients with locally advanced rectal cancer (LARC). However, its role is controversial. We aimed to develop a pretreatment MRI-based deep learning model to predict LR, DM, and overall survival (OS) over 5 years after surgery and to identify patients benefitting from adjuvant chemotherapy (AC).

View Article and Find Full Text PDF

Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related mortality globally with limited effective treatment options. Although the combination of immunotherapy and chemotherapy has been attempted in clinical trials to treat PDAC, the results are not promising. Therefore, in this study, we explored the application of a novel combination strategy with disulfiram (DSF) to enhance the treatment efficacy of PDAC as well as its underlying molecular mechanism.

View Article and Find Full Text PDF